Price $1.02 |
Market Cap
121M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
56.4
|
P/B
3.19
|
P/S
1.84
|
Dividend %
-
|
|
P/CF
3.4
|
P/FCF
-
|
Op. Cash Flow
-9.8K
|
FCF
-0.2
|
|
Op. Margin
18.30%
|
Net Margin
13.20%
|
ROE
199.40%
|
ROI
-77.00%
|
|
ROA
13.30%
|
EPS Growth
122.00%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
